GEM ETF Analysis: Goldman Sachs ActiveBeta | NYSE
Diversified Emerging Mkts | NYSE, USA | Market Cap: 1.739m USD | 12M Return: 32.2% | US3814302069 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.86M
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Goldman Sachs ActiveBeta® Emerging Markets Equity ETF (GEM) is a U.S.-listed exchange-traded fund that seeks to track an underlying index of equity securities from emerging market issuers. To meet its investment objective, the fund commits at least 80% of its assets to securities included in the index, including depositary receipts and the underlying stocks backing those receipts. Launched in September 2015, the ETF operates as a pooled investment vehicle traded on the NYSE, offering investors broad, diversified access to developing-market equities through a single, exchange-traded security.
As an ActiveBeta-branded product, the fund reflects Goldman Sachs factor-based (or smart beta) investment approach, which uses rules-based weighting on characteristics such as value, momentum, quality, and low volatility rather than traditional market-capitalization weighting. Its classification within the Diversified Emerging Markets category signals exposure across multiple countries and sectors within the developing world, providing geographic and economic diversification beyond a single emerging economy.
- Emerging market equities rise as dollar weakens and Fed cuts rates
- Goldman Sachs Asset Management AUM grows with EM ETF inflows
- Fee competition intensifies from Vanguard and iShares EM ETFs
As of September 22, 2026, the stock is trading at USD 52.69 with a total of 73,247 shares traded. Over the past week, the price has changed by +4.50%, over one month by +2.94%, over three months by -2.59% and over the past year by +32.21%.
Current recommended Stop Loss: 50.60 (which is 4% or 2.7 ATR below the current price).
Goldman Sachs ActiveBeta has no consensus analysts rating.